← All indications
Marijuana Abuse
Use of marijuana associated with abnormal psychological, social, and or occupational functioning.
Subtype terms (1)
More specific conditions that are subtypes of Marijuana Abuse in the MeSH hierarchy.
Drugs by status
Phase 4 trials (12)
Phase 3 trials (6)
Phase 2 trials (19)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (18)
- Eli Lilly
- National Institute on Drug Abuse (NIDA)
- Dartmouth University
- University of Washington
- Michigan State University
- Queen's University, Belfast
- Southern Illinois University
- University of Miami
- University of Missouri, Kansas City
- University of South Carolina
- University of California, San Francisco
- University of Cincinnati
- University of Colorado, Denver
- Medical University of South Carolina
- Free University of Brussels
- University of Massachusetts
- Department of Veteran Affairs
- Yeshiva University
Organization Involved with Phase 3 Indications (14)
- GW Pharmaceuticals Ltd.
- University of London
- Johns Hopkins University
- Mclean Hospital
- Silesian University of Medicine
- Columbia University
- University of British Columbia
- University of California, Davis
- University of California, San Diego
- Hebrew University
- The University of Hong Kong
- Brain & Behavior Research Foundation
- Assistance Publique - Hôpitaux de Paris
- Tikun Olam
Organization Involved with Phase 2 Indications (40)
- Alkermes
- Hamilton Health Sciences Corporation
- Research Foundation for Mental Hygiene, Inc.
- National Institutes of Health (NIH)
- National Institute on Aging (NIA)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- University of Pennsylvania
- University of Pittsburgh
- Brown University
- Harvard University
- McMaster University
- Multidisciplinary Association for Psychedelic Studies
- RTI International
- Sheppard Pratt Health System
- Sydney South West Area Health Service
- University of Kentucky
- University of Maryland
- University of Sydney
- University of Toronto
- Yale University
- Tel Aviv University
- University of California, Los Angeles
- University of Copenhagen
- University of Texas at Houston
- Scripps
- University of Paris
- University of New South Wales
- Corella Drug Treatment Service
- National Multiple Sclerosis Society
- American Academy of Child Adolescent Psychiatry.
- +10 more
Organization Involved with Phase 1 Indications (30)
- Kite Pharma, Inc.
- One World Cannabis Ltd.
- Maastricht University
- Indiana University
- Montana State University
- New York University
- Oregon Health and Science University
- The Mind Research Network
- University of Guelph
- Utrecht University
- Wayne State University
- University of Vermont
- University of Virginia
- University of Connecticut
- Food and Drug Administration
- Battelle
- Vince & Associates
- Algorithme Pharma Inc
- Uniformed Services University of Health Sciences
- Technion University
- National Institute of Public Health and the Environment, the Netherlands
- University of Illinois at Chicago
- Massachusetts Institute of Technology
- NHTSA
- Government of Netherlands
- Institut Hospital del Mar d'Investigacions Mèdiques
- KGK Science Inc.
- The Connecticut Hospice Inc.
- Connecticut Pharmaceutical Solutions
- New Age Ventures LLC
Organization Involved with Other Experimental Indications (9)